The enhancement of Nrf2 transcription with sulforaphane or melatonin could benefit patients with LONG COVID (Post-Acute Sequelae of SARS-CoV-2 or Post-COVID-Syndrome), a significant proportion (approximately 40%) of individuals with COVID-19 experiencing a variety of symptoms (loss of smell and/or taste, fatigue, cough, aching pain, brain fog, insomnia, shortness of breath, and tachycardia) after 12 weeks (Jarrott et al., 2022
According to Google search data, about 3,000 people per month are asking this question, so its clearly a significant concern
EMT and MET: necessary or permissive for metastasis
Compared to typical rib fracture recovery without intervention, which averages 6-12 weeks to functional recovery with 60% of patients still not at full work capacity at six months, users report BPC-157 may compress this timeline by 20-40%
195: A2446
That's a fundamentally different proposition from administering a synthetic analog